Dalal Street Investment Journal - December 18, 2023
Dalal Street Investment Journal - December 18, 2023
Nur abonnieren Dalal Street Investment Journal
Diese Ausgabe kaufen $1.99
Subscription plans are currently unavailable for this magazine. If you are a Magzter GOLD user, you can read all the back issues with your subscription. If you are not a Magzter GOLD user, you can purchase the back issues and read them.
In dieser Angelegenheit
Cover Story: Is The Adani Group Rally Sustainable?
The remarkable surge in Adani Group’s stock prices has reignited the attention of both traders and investors. Many are now pondering whether these stocks still have potential for further growth and whether it’s the right time to enter the market. The report takes a closer look at the scenario
MF - Cover Story
Pharma Funds : Investment Potential
Investors often assume that investing in the pharmaceutical sector is a safe bet given that its products and services are always in demand. However, investing in pharmaceutical funds requires a constant study of the market and the sector. Moreover, as they are more focused on a single sector, they offer no diversification benefit. Hence, even though they offer potentially higher risk, their underlying return is also on the higher end. Therefore, before you head towards investing in them, understand your risk profile, investment objectives and time horizon
Upward Surge In Markets Triggers Optimism
BSE Sensex and Nifty 50 reached unprecedented milestones of 70,000 and 21,000, respectively, in an unbroken uptrend, driven by robust growth projections and a decisive electoral mandate
2 mins
TATA POWER COMPANY: IN A POWERFUL SPACE
HERE IS WHY - Leading position in the power sector Developing next-gen charging solutions Integration with other Tata Group companies
2 mins
VASCON ENGINEERS: BUILDING A FORTUNE
HERE IS WHY - An excellent track record in construction Infrastructure boost in favour of the company Sound financial strategies in place
2 mins
ITD Cementation India Limited: Cementing A Bright Future
The company maintains a robust and diversified order book, totalling ₹22,080 crore as of September 30, 2023, ensuring multiyear revenue visibility. It anticipates strong revenue growth of approximately 25 per cent for FY25, building on the guidance of ₹7,000 crore revenues provided for FY24
6 mins
Salasar Techno Engineering Bags Contract Valued At ₹3,640 Million
Awarded by the Tamil Nadu Generation and Distribution Corporation Limited, the contract includes the supply, erection and installation of feeder segregation, high-voltage distribution system and separation of double distribution transformer along with the augmentation of 33 KV lines
2 mins
"Expect Nifty To Reach 21,500 Level till the Budget"
Overall Debt/EBITDA has improved marginally, with defence, We expect sustained momentum in India's robust economic growth, coupled with increased government capital expenditure in the lead-up to the elections, asserts R Venkataraman, Chairman, IIFL Securities.
3 mins
Is The Adani Group Rally Sustainable?
The remarkable surge in Adani Group's stock prices has reignited the attention of both traders and investors. Many are now pondering whether these stocks still have potential for further growth and whether it's the right time to enter the market. The report takes a closer look at the scenario
9 mins
"The Indian Breweries & Distilleries Industry is in a Very Exciting Growth Phase"
An interview with Amit Dahanukar Chairman and Managing Director
5 mins
"We are moving from Local Rail Infra to Global All Infra"
An interview with Pradeep Gaur Chairman and Managing Director, Rail Vikas Nigam Ltd.
3 mins
Special Supplement
Economic & Sectoral Review
3 mins
Kerbside
The recommendations provided in this column are taken from various market sources such as brokers, analysts, dealers and investment strategists, etc. These recommendations may not be backed by strong fundamentals. Therefore we advise readers to use their own discretion before investing in these recommendation
2 mins
Pharma Funds: Investment Potential
Investors often assume that investing in the pharmaceutical sector is a safe bet given that its products and services are always in demand. However, investing in pharmaceutical funds requires a constant study of the market and the sector. Moreover, as they are more focused ona single sector, they offer no diversification benefit. Hence, even though they offer potentially higher risk, their underlying return is also on the higher end. Therefore, before you head towards investing in them, understand your risk profile, investment objectives and time horizon
6 mins
Wealth Creation Through Mutual Funds: A Strategic Approach
At the core of mutual funds lies the principle of diversification. With shares of over 4,000 listed companies and thousands of bonds and other securities available for trade, making choices can be challenging for investors. However, by pooling money from various investors, mutual funds construct portfolios that span a broad spectrum of stocks, bonds, and other securities.
2 mins
Balanced Advantage Funds: The Pros & Cons
A prudent strategy for conservative to moderate investors involves considering funds that blend equity and debt, offering stability amid equity fluctuations. Balanced advantage funds which invest in both equity and debt present an appealing option
5 mins
Dalal Street Investment Journal Magazine Description:
Verlag: DSIJ Pvt. Ltd.
Kategorie: Business
Sprache: English
Häufigkeit: Fortnightly
Thirty one-years old but conventional, Dalal Street Investment Journal (DSIJ), India’s No 1 equity research and capital investment magazine is published every fortnight to cater to the needs of its reader-investors. Armed with a set of chosen experts on markets and corporate India, the fortnightly magazine has its focus on stock market research and recommendations, capital market analysis, personal finance investment advice and also analysis of various economic activities in the country along with its impact on Indian share markets. This is the one and only complete resource guide for a wide loyal base of over 8 lakh HNI readers.
- Jederzeit kündigen [ Keine Verpflichtungen ]
- Nur digital